These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


104 related items for PubMed ID: 7318125

  • 1. Pharmacokinetics of Malonato (1,2 diaminocyclohexane) platinum.
    Kelsen DP, Ribaud P, Alcock N, Burchenal JH, Young CW, Mathe G.
    Cancer Clin Trials; 1981; 4(4):429-31. PubMed ID: 7318125
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II).
    Belt RJ, Himmelstein KJ, Patton TF, Bannister SJ, Sternson LA, Repta AJ.
    Cancer Treat Rep; 1979; 63(9-10):1515-21. PubMed ID: 498151
    [Abstract] [Full Text] [Related]

  • 3. A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors.
    Rademaker-Lakhai JM, Terret C, Howell SB, Baud CM, De Boer RF, Pluim D, Beijnen JH, Schellens JH, Droz JP.
    Clin Cancer Res; 2004 May 15; 10(10):3386-95. PubMed ID: 15161693
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacokinetics of cis-dichlorodiammineplatinum (II)].
    Horiuchi M, Inuyama Y, Kohno N, Mashino S, Fujii M.
    Gan To Kagaku Ryoho; 1982 Apr 15; 9(4):632-7. PubMed ID: 6892197
    [Abstract] [Full Text] [Related]

  • 5. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
    Meerum Terwogt JM, Groenewegen G, Pluim D, Maliepaard M, Tibben MM, Huisman A, ten Bokkel Huinink WW, Schot M, Welbank H, Voest EE, Beijnen JH, Schellens JM.
    Cancer Chemother Pharmacol; 2002 Mar 15; 49(3):201-10. PubMed ID: 11935212
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacokinetics of cisplatin and the effect of sodium thiosulfate].
    Hayata S, Hitoshi T, Kiyokawa K, Esaki S, Mihashi S, Hirano M.
    Gan To Kagaku Ryoho; 1984 Nov 15; 11(11):2356-61. PubMed ID: 6541891
    [Abstract] [Full Text] [Related]

  • 7. [Studies on the appropriate administration of cisplatin based on pharmacokinetics and toxicity].
    Kitajima K, Fukuoka M, Kobayashi S, Kusunoki Y, Takada M, Negoro S, Matsui K, Sakai N, Ryu S, Takifuji N.
    Gan To Kagaku Ryoho; 1987 Aug 15; 14(8):2517-23. PubMed ID: 3039920
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients.
    Liu J, Kraut E, Bender J, Brooks R, Balcerzak S, Grever M, Stanley H, D'Ambrosio S, Gibson-D'Ambrosio R, Chan KK.
    Cancer Chemother Pharmacol; 2002 May 15; 49(5):367-74. PubMed ID: 11976830
    [Abstract] [Full Text] [Related]

  • 9. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov 15; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 10. Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II).
    Kelsen DP, Scher H, Alcock N, Leyland-Jones B, Donner A, Williams L, Greene G, Burchenal JH, Tan C, Philips FS, Young CW.
    Cancer Res; 1982 Nov 15; 42(11):4831-5. PubMed ID: 7127319
    [Abstract] [Full Text] [Related]

  • 11. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
    Kim DK, Kim HT, Cho YB, Kim TS, Kim KH, Hong WS.
    Anticancer Res; 1996 Nov 15; 16(1):251-6. PubMed ID: 8615617
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
    Mok TS, Kanekal S, Lin XR, Leung TW, Chan AT, Yeo W, Yu S, Chak K, Leavitt R, Johnson P.
    Cancer; 2001 Jun 15; 91(12):2369-77. PubMed ID: 11413527
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of intravenously injected [3H]tetrachloro(D,L-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin) in mice.
    Kido Y, Khokhar AR, Siddik ZH.
    Drug Metab Dispos; 1992 Jun 15; 20(5):673-8. PubMed ID: 1358571
    [Abstract] [Full Text] [Related]

  • 14. Clinical pharmacology and pharmacokinetics of cis-platinum and analogs.
    Ribaud P, Gouveia J, Bonnay M, Mathe G.
    Cancer Treat Rep; 1981 Jun 15; 65 Suppl 3():97-105. PubMed ID: 7049371
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.
    Harland SJ, Newell DR, Siddik ZH, Chadwick R, Calvert AH, Harrap KR.
    Cancer Res; 1984 Apr 15; 44(4):1693-7. PubMed ID: 6367971
    [Abstract] [Full Text] [Related]

  • 16. Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients.
    Gamelin E, Bouil AL, Boisdron-Celle M, Turcant A, Delva R, Cailleux A, Krikorian A, Brienza S, Cvitkovic E, Robert J, Larra F, Allain P.
    Clin Cancer Res; 1997 Jun 15; 3(6):891-9. PubMed ID: 9815764
    [Abstract] [Full Text] [Related]

  • 17. Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.
    Belliveau JF, Posner MR, Ferrari L, Crabtree GW, Cummings FJ, Wiemann MC, O'Leary GP, Griffin H, Phaneuf MA, O'Rourke A.
    Cancer Treat Rep; 1986 Oct 15; 70(10):1215-7. PubMed ID: 3756943
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic study of Cis-dichlorodiammine platinum II, in children after rapid infusion.
    Cano JP, Catalin J, Rigault JP, Bues-Charbit M, Placidi M, Raybaud C, Bernard JL.
    Biomedicine; 1981 Dec 15; 34(3):146-53. PubMed ID: 7199945
    [Abstract] [Full Text] [Related]

  • 19. Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy.
    Pendyala L, Schwartz G, Smith P, Zdanowicz J, Murphy M, Hausheer F.
    Cancer Chemother Pharmacol; 2003 May 15; 51(5):376-84. PubMed ID: 12682786
    [Abstract] [Full Text] [Related]

  • 20. Kinetics of platinum in cancer patients treated with cisplatin at different doses.
    Fracasso ME, Apostoli P, Benoni G, Bonetti A, Griso C, Leone R.
    Drugs Exp Clin Res; 1987 May 15; 13(6):367-72. PubMed ID: 3652926
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.